1. Ireland
  2. All 3M Products
  3. Medical
  4. Bandages & Dressings
  5. Antimicrobial Wound Dressings
  6. 3M™ Kerracel™ Ag Gelling Fiber Dressing, CWL1182, 20 cm x 30 cm, 5/Ct, 10Cts/Cs

3M™ Kerracel™ Ag Gelling Fiber Dressing, CWL1182, 20 cm x 30 cm, 5/Ct, 10Cts/Cs

  • 3M ID 7100272348
  • UPC 05060077235502

Antimicrobial

A fast and powerful silver technology

View more details

Details

Highlights
  • Antimicrobial
  • A fast and powerful silver technology

This dressing is a gelling fiber silver dressing that uses the combination of an enhanced carboxymethyl cellulose (CMC) dressing and the advanced silver technology – Ag OXYSALTS™ Technology - to create the optimal wound healing environment.

This dressing is the only gelling dressing with Ag OXYSALTS™ Technology (Ag3+), providing up to 6 times more power than traditional silvers (Ag1+) *1:

  • Kills bacteria within a biofilm and prevents biofilm re-formation*,2
  • Quickly kills at least 99.999% (5 log) of a broad spectrum of bacteria*,3,4

A proven substrate, this dressing is a carboxymethyl cellulose (CMC) gelling fiber dressing designed to help create the optimal healing environment*:

  • Quickly absorbs and locks away exudate and its harmful components5,6
  • Micro-contours to the wound bed to eliminate dead space where bacteria can live7
  • Designed to reduce the risk of periwound maceration6
  • Strong enough to be removed in one piece8

*As demonstrated in vitro

1 Spina C. Silver I, II, III: Chemical characteristics, properties, and anti-microbial activity. Crawford Healthcare Ltd.
2 Evaluation of antimicrobial activity of KERRACEL™ Ag and Aquacel® Ag Extra™ against in vitro biofilms. CHC R541. 2017. Crawford Healthcare Ltd.
3 Antibacterial efficacy of KERRACEL™ Ag and Aquacel® Ag Extra™ against planktonic species over 7 days in vitro. CHC R539. 2017. Crawford Healthcare Ltd.
4 Rate of antibacterial efficacy of KERRACEL™ Ag and Aquacel® Ag Extra™ against S. aureus and P. aeruginosa in vitro. CHC R540. 2017. Crawford Healthcare Ltd.
5 Evaluation of KERRACEL™ Ag and Aquacel® Ag Extra™ sequester bacteria. CHC R543. 2017. Crawford Healthcare Ltd.
6 In vitro fluid handling properties of KERRACEL™ Ag and Aquacel® Ag Extra™. CHC R545. 2017. Crawford Healthcare Ltd.
7 Zone of inhibition evaluation of KERRACEL™ Ag and Aquacel® Ag Extra™ to uniformly kill planktonic bacteria. CHC R544. 2017. Crawford Healthcare Ltd.
8 An assessment of silver ribbon dressings using a porcine cavity model. CHC R530. 2017. Crawford Healthcare Ltd.

Ag OXYSALTS™ Technology is a trademark of Argent Limited Partnership

Specifications

¹ Spina C. Silver I, II, III: Chemical characteristics, properties, and anti-microbial activity. Crawford Healthcare Ltd. ² Evaluation of antimicrobial activity of KERRACEL™ Ag and Aquacel® Ag Extra™ against in vitro biofilms. CHC R541. 2017. Crawford Healthcare Ltd. ³ Antibacterial efficacy of KERRACEL™ Ag and Aquacel® Ag Extra™ against planktonic species over 7 days in vitro. CHC R539. 2017. Crawford Healthcare Ltd. ⁴ Rate of antibacterial efficacy of KERRACEL™ Ag and Aquacel® Ag Extra™ against S. aureus and P. aeruginosa in vitro. CHC R540. 2017. Crawford Healthcare Ltd. ⁵ Evaluation of KERRACEL™ Ag and Aquacel® Ag Extra™ sequester bacteria. CHC R543. 2017. Crawford Healthcare Ltd. ⁶ In vitro fluid handling properties of KERRACEL™ Ag and Aquacel® Ag Extra™. CHC R545. 2017. Crawford Healthcare Ltd. ⁷ Zone of inhibition evaluation of KERRACEL™ Ag and Aquacel® Ag Extra™ to uniformly kill planktonic bacteria. CHC R544. 2017. Crawford Healthcare Ltd. ⁸ An assessment of silver ribbon dressings using a porcine cavity model. CHC R530. 2017. Crawford Healthcare Ltd. Ag OXYSALTS™ Technology is a trademark of Argent Limited Partnership *as demonstrated in vitro